Active Ingredient(s):Vibegron FDA Approved: * December 23, 2020 Pharm Company: *UROVANT Category:Urinary System
Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder.
Vibegron (other names: RVT-901; MK4618; KRP114V; URO-901) is a selective beta 3 adrenergic receptor agonist.
The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection.
It was approved for medical use in the United States in December 202...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion